# | Title | Journal | Year | Citations |
---|
1 | DNA methylation-based classification of central nervous system tumours | Nature | 2018 | 1,872 |
2 | 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer | Journal of Nuclear Medicine | 2019 | 874 |
3 | Brain tumour cells interconnect to a functional and resistant network | Nature | 2015 | 787 |
4 | Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein | Journal of Nuclear Medicine | 2018 | 522 |
5 | 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers | Journal of Nuclear Medicine | 2019 | 468 |
6 | A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts | Journal of Nuclear Medicine | 2018 | 453 |
7 | NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential | Signal Transduction and Targeted Therapy | 2020 | 386 |
8 | Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy | European Journal of Nuclear Medicine and Molecular Imaging | 2014 | 319 |
9 | Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention | Journal of Nuclear Medicine | 2019 | 281 |
10 | MR-guidance in clinical reality: current treatment challenges and future perspectives | Radiation Oncology | 2019 | 252 |
11 | Sarcoma classification by DNA methylation profiling | Nature Communications | 2021 | 237 |
12 | A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors | | 2018 | 233 |
13 | Technical design and concept of a 0.35 T MR-Linac | Clinical and Translational Radiation Oncology | 2019 | 210 |
14 | 68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients | European Journal of Nuclear Medicine and Molecular Imaging | 2016 | 194 |
15 | Tweety-Homolog 1 Drives Brain Colonization of Gliomas | Journal of Neuroscience | 2017 | 129 |
16 | Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—A pooled analysis of the German working group “stereotactic radiotherapy” | Lung Cancer | 2016 | 128 |
17 | Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases | JAMA Oncology | 2020 | 122 |
18 | Resection after neoadjuvant therapy for locally advanced, “unresectable” pancreatic cancer | Surgery | 2012 | 118 |
19 | The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases | BMC Cancer | 2018 | 115 |
20 | Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas | Journal of Nuclear Medicine | 2021 | 113 |
21 | A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma | Clinical Cancer Research | 2014 | 111 |
22 | Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy | Journal of Nuclear Medicine | 2020 | 110 |
23 | Re-resection for Isolated Local Recurrence of Pancreatic Cancer is Feasible, Safe, and Associated with Encouraging Survival | Annals of Surgical Oncology | 2013 | 109 |
24 | The Role of68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience | Journal of Nuclear Medicine | 2020 | 106 |
25 | Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy | Radiotherapy and Oncology | 2016 | 101 |
26 | N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma | Neuro-Oncology | 2019 | 100 |
27 | IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT | European Journal of Nuclear Medicine and Molecular Imaging | 2019 | 94 |
28 | EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non‐small cell lung cancer | International Journal of Cancer | 2018 | 93 |
29 | 68Ga-FAPI-PET/CT in patients with various gynecological malignancies | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 91 |
30 | Mesenchymal stem cells – A new hope for radiotherapy-induced tissue damage? | Cancer Letters | 2015 | 83 |
31 | 68Ga-PSMA-11 PET/CT in Newly Diagnosed Carcinoma of the Prostate: Correlation of Intraprostatic PSMA Uptake with Several Clinical Parameters | Journal of Nuclear Medicine | 2017 | 81 |
32 | Adaptive radiotherapy for advanced lung cancer ensures target coverage and decreases lung dose | Radiotherapy and Oncology | 2016 | 79 |
33 | Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence | Journal of Nuclear Medicine | 2021 | 77 |
34 | Next generation multi-scale biophysical characterization of high precision cancer particle radiotherapy using clinical proton, helium-, carbon- and oxygen ion beams | Oncotarget | 2016 | 72 |
35 | Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic | Oncotarget | 2015 | 72 |
36 | Recent advances in Surface Guided Radiation Therapy | Radiation Oncology | 2020 | 71 |
37 | Mesenchymal Stem Cells Retain Their Defining Stem Cell Characteristics After Exposure to Ionizing Radiation | International Journal of Radiation Oncology Biology Physics | 2013 | 70 |
38 | The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases | BMC Cancer | 2019 | 68 |
39 | Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma | International Journal of Cancer | 2019 | 67 |
40 | FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis? | Cancers | 2021 | 67 |
41 | Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients | European Radiology | 2019 | 64 |
42 | Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients | Oncotarget | 2018 | 63 |
43 | Clinical applications of proton and carbon ion therapy | Seminars in Oncology | 2019 | 62 |
44 | Loss of SOX2 expression induces cell motility via vimentin up‐regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma | Molecular Oncology | 2015 | 60 |
45 | [153Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma | European Journal of Nuclear Medicine and Molecular Imaging | 2021 | 60 |
46 | Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives | Physica Medica | 2021 | 60 |
47 | Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy | Radiation Oncology | 2015 | 58 |
48 | FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis | European Journal of Nuclear Medicine and Molecular Imaging | 2019 | 58 |
49 | Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T | Journal of Magnetic Resonance Imaging | 2019 | 58 |
50 | Non-invasive monitoring of therapeutic carbon ion beams in a homogeneous phantom by tracking of secondary ions | Physics in Medicine and Biology | 2013 | 57 |